Cadmium induced hypertension.

Area of Science:

• Toxicology
• Cardiovascular Physiology
• Neuropharmacology

Background:

• Cadmium is a toxic heavy metal with known cardiovascular effects.
• Understanding cadmium's impact on blood pressure regulation is crucial for public health.
• Previous studies suggest cadmium may influence blood pressure, but routes of administration and duration effects require further investigation.

Purpose of the Study:

• To investigate the hypertensive effects of cadmium acetate administered via intravenous (i.v.) and intracerebroventricular (i.c.v.) routes in rats.
• To determine the dose and time dependency of cadmium-induced hypertension.
• To assess the duration of the hypertensive response after repeated cadmium exposure.

Main Methods:

• Male Sprague-Dawley rats were anesthetized with urethane.
• Cadmium acetate was administered intravenously (i.v.) at doses of 0.32, 1.0, and 3.2 mg/kg.
• Cadmium acetate was administered intracerebroventricularly (i.c.v.) at doses of 1, 3.2, and 10 microg.
• Repeated administration (1 mg/kg i.p. for 5 days) was followed by blood pressure monitoring at various intervals post-treatment.

Main Results:

• Intravenous cadmium injection caused a transient drop followed by a sustained increase in blood pressure.
• Intracerebroventricular cadmium administration resulted in a statistically significant hypertensive response (p<0.01).
• Repeated intraperitoneal cadmium administration led to elevated blood pressure, with significant increases observed up to 10 days after cessation of treatment.

Conclusions:

• Cadmium exposure through both i.v. and i.c.v. routes induces a hypertensive response in rats.
• The hypertensive effects of cadmium are dose-dependent and can persist for approximately two weeks.
• These findings highlight the significant cardiovascular risks associated with cadmium exposure.